Related Experiment Video
Updated: Sep 9, 2025

Synthesis of a Borylated Ibuprofen Derivative Through Suzuki Cross-Coupling and Alkene Boracarboxylation Reactions
Published on: November 30, 2022
A novel bisphenol A alternative, DD-70, may negatively affect haemostasis through cyclooxygenase 1 inhibition
Marcel Hrubša1, Alina Soloviova2, Catherine Gunaseelan1
1Department of Pharmacology and Toxicology, Faculty of Pharmacy, Charles University, Akademika Heyrovského 1203, 500 05 Hradec Králové, Czech Republic.
Abstract:
Bisphenols, frequently used in the plastics industry, have been recognized as environmental pollutants. Bans on bisphenol A use led to the replacement by alternatives. There are, however, almost no data on their biological effects in humans. This study has focused on the potential negative impact of four alternatives to bisphenol A on haemostasis and erythrocytes. Acute toxicity was assessed using rat and human erythrocytes, followed by a lactate dehydrogenase assay. The impact on platelet aggregation was initially screened in whole human blood, followed by a thorough investigation of the mechanism of action at different levels. Haemocoagulation was also assessed. The erythrocyte toxicity of all tested compounds was relatively low, with TC50s above 500 μM in all cases. None of the compounds augmented platelet aggregation, but DD-70 was a potent antiplatelet compound with an IC50 of 5.0 ± 2.7 µM in arachidonic acid-triggered platelet aggregation. DD-70 also blocked other aggregation pathways, and its mechanism was primarily based on the inhibition of cyclooxygenase 1. Only high concentrations of the tested bisphenol A alternatives (≥100 µM) influenced blood coagulation. Based on these results, DD-70 may affect platelet aggregation and have clinical consequences due to its low IC50, however, this hypothesis requires a human exposure study to be confirmed. ENVIRONMENTAL IMPLICATIONS: Due to the enormous amounts of bisphenols used in the chemical industry, they represent important environmental pollutants. Their accumulation both in the environment and the human body has a negative influence on nature and the health of the population. While the most infamous representative, bisphenol A, is being banned in developed countries, the lack of knowledge on the biological effects of its substitutes poses a grave danger. Our study shows that one of these alternatives may, in fact, negatively impact the haemostasis of both humans and animals, which may have negative implications, in particular for occupational healthcare and food production.
More Related Videos
Related Concept Videos
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...

